Coral Laboratories Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 476417,
    "name": "Coral Labs.",
    "stock_name": "Coral Labs.",
    "full_name": "Coral Laboratories Ltd",
    "name_url": "stocks-analysis/coral-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "362.05",
    "chg": -19,
    "chgp": "-4.99%",
    "dir": -1,
    "prev_price": "381.05",
    "mcapval": "139.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524506,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE683E01017",
    "curr_date": "Mar 27",
    "curr_time": "",
    "bse_nse_vol": "2.98 k",
    "exc_status": "Active",
    "traded_date": "Mar 27, 2026",
    "traded_date_str": "2026 03 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/coral-labs-476417-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-hits-52-week-low-amidst-continued-decline-3919608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3919608.png",
        "date": "2026-03-27 12:37:28",
        "description": ""
      },
      {
        "title": "Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-falls-to-52-week-low-amid-continued-downtrend-3916024",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3916024.png",
        "date": "2026-03-25 10:43:27",
        "description": ""
      },
      {
        "title": "Coral Laboratories Ltd Falls to 52-Week Low of Rs 387.8 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-hits-52-week-low-amidst-continued-decline-3910282",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3910282.png",
        "date": "2026-03-24 11:14:06",
        "description": "For the third consecutive session, Coral Laboratories Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 387.8 on 24 Mar 2026. This marks a significant drop of 7.64% over the last three days, underscoring persistent selling pressure despite an intraday high of Rs 417 earlier today."
      },
      {
        "title": "Markets Rally, But Coral Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/coral-laboratories-ltd-stock-hits-52-week-low-amidst-continued-downtrend-3906966",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_priceRelatedfactors_3906966.png",
        "date": "2026-03-23 10:24:26",
        "description": ""
      },
      {
        "title": "Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3895898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_mojoScore_3895898.png",
        "date": "2026-03-17 08:24:17",
        "description": "Coral Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 16 March 2026. This revision reflects deteriorating technical indicators, disappointing financial trends, and persistent valuation concerns, signalling heightened caution for investors amid ongoing underperformance relative to the broader market."
      },
      {
        "title": "Coral Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-financials-3882103",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/CoralLaboratori_mojoScore_3882103.png",
        "date": "2026-03-10 08:18:18",
        "description": "Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 9 March 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but improved outlook amid persistent operational headwinds and valuation considerations."
      },
      {
        "title": "Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3857422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CoralLaboratori_mojoScore_3857422.png",
        "date": "2026-02-26 08:10:38",
        "description": "Coral Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 25 Feb 2026, reflecting deteriorating fundamentals and increasingly negative technical signals. The pharmaceutical company’s financial performance has worsened significantly, with declining sales and profits, while technical indicators have shifted towards bearish trends. This comprehensive downgrade is driven by four key parameters: Quality, Valuation, Financial Trend, and Technicals."
      },
      {
        "title": "Coral Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-financials-3851069",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CoralLaboratori_mojoScore_3851069.png",
        "date": "2026-02-23 08:09:02",
        "description": "Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Feb 2026, primarily driven by a shift in technical indicators despite ongoing financial challenges. The pharmaceutical company’s Mojo Score now stands at 31.0, reflecting a cautious but slightly improved outlook amid persistent operational headwinds and valuation considerations."
      },
      {
        "title": "Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/coral-laboratories-ltd-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3843759",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/CoralLaboratori_mojoScore_3843759.png",
        "date": "2026-02-17 08:31:11",
        "description": "Coral Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 16 Feb 2026, reflecting deteriorating fundamentals and increasingly bearish technical indicators. The pharmaceutical company’s financial performance has worsened significantly, with declining sales and profits, while technical analysis signals a negative trend. This comprehensive review examines the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that triggered the rating change."
      }
    ],
    "total": 159,
    "sid": "476417",
    "stock_news_url": "https://www.marketsmojo.com/news/coral-laboratories-476417"
  },
  "announcements": [
    {
      "caption": "Completion Of Capacity Expansion At Dehradun Plant",
      "datetime": "23-Mar-2026",
      "details": "The company has successfully completed capacity expansion at Dehradun plant. Please refer the attached documents.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On February 13 2026",
      "datetime": "13-Feb-2026",
      "details": "Outcome of board meeting held on Friday 13 2026",
      "source": "BSE"
    },
    {
      "caption": "Financial Result For The Quarter Ended December 31 2026",
      "datetime": "13-Feb-2026",
      "details": "Submission of financial result for the quarter ended December 31 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Coral Laboratories Ltd has declared <strong>15%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low

2026-03-27 12:37:28

Read full news article

Five Consecutive Losses Push Coral Laboratories Ltd to a New 52-Week Low

2026-03-25 10:43:27

Read full news article

Coral Laboratories Ltd Falls to 52-Week Low of Rs 387.8 as Sell-Off Deepens

2026-03-24 11:14:06

For the third consecutive session, Coral Laboratories Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 387.8 on 24 Mar 2026. This marks a significant drop of 7.64% over the last three days, underscoring persistent selling pressure despite an intraday high of Rs 417 earlier today.

Read full news article

Markets Rally, But Coral Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-23 10:24:26

Read full news article

Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-03-17 08:24:17

Coral Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 16 March 2026. This revision reflects deteriorating technical indicators, disappointing financial trends, and persistent valuation concerns, signalling heightened caution for investors amid ongoing underperformance relative to the broader market.

Read full news article

Coral Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials

2026-03-10 08:18:18

Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 9 March 2026, driven primarily by a shift in technical indicators despite ongoing financial challenges. The company’s Mojo Score now stands at 31.0, reflecting a cautious but improved outlook amid persistent operational headwinds and valuation considerations.

Read full news article

Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-02-26 08:10:38

Coral Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 25 Feb 2026, reflecting deteriorating fundamentals and increasingly negative technical signals. The pharmaceutical company’s financial performance has worsened significantly, with declining sales and profits, while technical indicators have shifted towards bearish trends. This comprehensive downgrade is driven by four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Coral Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Weak Financials

2026-02-23 08:09:02

Coral Laboratories Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 20 Feb 2026, primarily driven by a shift in technical indicators despite ongoing financial challenges. The pharmaceutical company’s Mojo Score now stands at 31.0, reflecting a cautious but slightly improved outlook amid persistent operational headwinds and valuation considerations.

Read full news article

Coral Laboratories Ltd Downgraded to Strong Sell Amid Weak Financials and Bearish Technicals

2026-02-17 08:31:11

Coral Laboratories Ltd has been downgraded from a Sell to a Strong Sell rating as of 16 Feb 2026, reflecting deteriorating fundamentals and increasingly bearish technical indicators. The pharmaceutical company’s financial performance has worsened significantly, with declining sales and profits, while technical analysis signals a negative trend. This comprehensive review examines the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that triggered the rating change.

Read full news article

View All News